Robert Bindert Huizinga, EVP of Research at Aurinia Pharmaceuticals Inc. (AUPH), sold 9,698 shares at $12.01 ($116K) on 2022-03-02, disclosed to the SEC on 2022-03-04.
Open-market sale of $116k AUPH by EVP of Research. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 4,849 | $58K | 50.0% |
| 2 | $12.01 | 4,849 | $58K | 50.0% |
| Total | $12.01 avg | 9,698 | $116K | 100% |
| Filing → |
| AUPH | SELL | 2021-09-14 | $885K | — | Filing → |
| AUPH | SELL | 2021-09-08 | $92K | — | Filing → |